ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Louisville, KY, USA:

A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This study will consist of...

Active, not recruiting
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Drug: imvotamab

Phase 1, Phase 2

IGM Biosciences

Louisville, Kentucky, United States and 26 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1

Acerta Pharma
Acerta Pharma

Louisville, Kentucky, United States and 31 other locations

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Louisville, Kentucky, United States and 125 other locations

of this study is to evaluate the safety and preliminary efficacy of ATA3219 in participants with relapsed/refractory (R/R) B-cell non-Hodgkin Lymphoma...

Enrolling
DLBCL Arising From Transformed Indolent Lymphoma
High-grade B-cell Lymphoma
Drug: ATA3219

Phase 1

Atara Biotherapeutics

Louisville, Kentucky, United States

A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...

Enrolling
EBV Associated Lymphoma
EBV Related Non-Hodgkin's Lymphoma
Drug: Nanatinostat in combination with valganciclovir

Phase 2

Viracta Therapeutics

Louisville, Kentucky, United States and 94 other locations

of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...

Active, not recruiting
Relapsed/Refractory Follicular Lymphoma
Relapsed/Refractory Large B Cell Lymphoma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 1

Allogene Therapeutics

Louisville, Kentucky, United States and 6 other locations

with various types of blood cancers:relapsed or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This t...

Active, not recruiting
Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Dexamethasone
Drug: Venetoclax

Phase 1

Pfizer
Pfizer

Louisville, Kentucky, United States and 61 other locations

This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...

Active, not recruiting
Mantle-Cell Lymphoma
Drug: Ibrutinib
Drug: Venetoclax

Phase 3

Pharmacyclics
Pharmacyclics

Louisville, Kentucky, United States and 119 other locations

The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...

Enrolling
Relapsed Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Drug: Oxaliplatin
Drug: Gemcitabine

Phase 3

ADC Therapeutics

Louisville, Kentucky, United States and 140 other locations

safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed mantle cell lymphoma...

Active, not recruiting
Mantle Cell Lymphoma
Drug: Rituximab
Drug: Bendamustine

Phase 3

Janssen
Janssen

Louisville, Kentucky, United States and 203 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems